Pharmacologic management of urinary incontinence.
Urinary incontinence is a highly prevalent and difficult to treat medical condition. For those who are affected, urinary incontinence produces profound modifications in lifestyle and perceived quality of life. Pharmacologic therapy clearly is beneficial for most types of urinary incontinence. The low therapeutic success of current treatments and obnoxious side effects, however, limit patient satisfaction and compliance. There is a considerable need for improved therapeutic options to treat this devastating condition.
Thomas
David R
DR
Division of Geriatric Medicine, Saint Louis University Health Sciences Center, 1402 South Grand Boulevard, Room M238, St. Louis, MO 63104, USA. thomasdr@slu.edu
D018674:Adrenergic Antagonists / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D014549:Urinary Incontinence / Q000188:drug therapy* / Q000209:etiology
D018674:Adrenergic Antagonists; D004791:Enzyme Inhibitors; D018727:Muscarinic Antagonists